Apoptosis, anoikis and their relevance to the pathobiology of colon cancer

Pathology International

Volumn 50, Issue 4, 2000, Pages 273-279

  Shanmugathasan, Minalini ^a   Jothy, Serge ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Anoikis; Apoptosis; Bcl 2; Caspase; Colon cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C OXIDASE; DNA; FAS ANTIGEN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CRYPT CELL; HOMEOSTASIS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; STEM CELL;

ADULT; APOPTOSIS; CASPASES; CELL DIVISION; CELL MOVEMENT; COLONIC NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033919727     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2000.01047.x     Document Type: Article

References (32)

1. 1 Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
2. 2 Frisch SM, Francis H. Disruption of epithelial cell matrix interactions induces apoptosis. J. Cell Biol. 1994; 124: 619-626.
3. 3 Meredith J, Fazeli B, Schwartz M. The extracellular matrix as a cell survival factor. Mol. Biol. Cell 1993; 4: 953-961.
4. 4 Beaulieu JF, Vachon PH. Reciprocal expression of laminin A-chain isoforms along the crypt-villus axis in the human small intestine. Gastroenterology 1994; 106: 829-839.
5. 5 Perreault N, Vachon PH, Beaulieu JF. Appearance and distribution of laminin A chain isoforms and integrin alpha 2, alpha 3, alpha 6, beta 1 and beta 4 subunits in the developing human small intestinal mucosa. Anat. Rec. 1995; 242: 242-250.
6. 6 Kumar CC. Signaling by integrin receptors. Oncogene 1998; 17: 1365-1373.
7. 7 Partik G, Kahl-Rainer P, Sedviy AD, Bursch W, Marian B. Apoptosis in human colorectal tumors: Ultrastructure and quantitative studies on tissue localization and association with Bak expression. Virch. Arch. 1998; 452: 415-420.
8. 8 Sincrope F, Roddey G, McDonnell J, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic development in human colorectum. Clin. Cancer Res. 1996; 2: 1999-2006.
9. 9 Yang H, Chow N, Sheu B, Chan S, Chien C, Su I. The role of Bcl-2 in the progression of the colorectal adenoma-carcinoma sequence. Anticancer Res. 1999; 19: 727-730.
10. 10 Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotoic pathway. Oncogene 1998; 17: 3237-3245.
11. 11 Thornberry NA, Lazebnik Y. Caspases. Enemies within. Science 1998; 281: 1312-1316.
12. 12 Buckley C, Pilling D, Henriquuez NV et al. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999; 397: 534-539.
13. 13 Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncology 1999; 11: 68-75.
14. 14 Reed JC. Bcl-2 Family of proteins. Oncogene 1998; 17: 3225-3236.
15. 15 Green D, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
16. 16 Honglin L, Zhu H, Xu C, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
17. 17 Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-299.
18. 18 Jothy S, Yuan SY, Shirota K. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new in vivo functional model. Am. J. Pathol. 1993; 143: 250-257.
19. 19 Jothy S, Munro SB, LeDuy L, McClure D, Blaschuk OW. Adhesion and anti-adhesion in cancer: What matters more? Cancer Metastasis Rev. 1995; 14: 363-376.
20. 20 Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of Bcl-2 protein family. Cancer Res. 1996; 56: 2849-2855.
21. 21 Krajewski S, Krajewska M, Shabaik A, Wang HG, Miyashita T, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 1994; 145: 1323-1336.
22. 22 Krajewska M, Wang HG, Krajewski S et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 1997; 57: 1605-1613.
23. 23 Grossmann J, Maxson JM, Whitcare CM. New isolation technique to study apoptosis in human intestinal epithelial cells. Am. J. Pathol. 1998; 153: 53-62.
24. 24 Rak J, Mitsuhashi Y, Sheehan C et al. Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cells variant selected for resistance to anoikis. Neoplasia 1999; 1: 23-30.
25. 25 Abdel-Rahmen WM, Georgiades IB, Curtis LJ, Arends MJ, Wyllie AH. Role of Bax mutations in mismatch repair-deficient colorectal carcinogenesis. Oncogene 1999; 18: 2139-2142.
26. 26 Hague A, Darfo Diaz G, Hicks DJ, Krajewski S, Reed JC, Paraskeva C. Bcl-2 and Bak play a pivotal role in sodium butyrate induced apoptosis in colonic epithelial cells: However, overexpression of Bcl-2 does not protect against Bak-mediated apoptosis. Int. J. Cancer 1997; 72: 898-905.
27. 27 Leonardos L, Butler LM, Hewett PJ, Zalewski PD, Cowled PA. The activity of caspase-3-like proteases is elevated during the development of colorectal carcinoma. Cancer Lett. 1999; 143: 29-35.
28. 28 Schwartz SJ, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 1999; 59: 2995-3002.
29. 29 Hoguen K, Yang X, Rosada C, Hamilton SR, August JT. CD44 expression in Colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys. 1994; 310: 504-507.
30. 30 Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-xL and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 1996; 56: 2422-2427.
31. 31 Rosen K, Rak J, Jin J, Kerbel RS, Newman MJ, Filmus J. Down-regulation of the proapoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr. Biol. 1998; 8: 1331-1334.
32. 32 Webb A, Cunningham D, Cotter F et al. Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 1997; 349: 1137-1141.